Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study
- PMID: 39669079
- PMCID: PMC11634424
- DOI: 10.21037/hbsn-24-583
Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study
Keywords: Pancreatic cancer; adjuvant chemotherapy; intraductal papillary mucinous neoplasm (IPMN); pancreatic ductal adenocarcinoma (PDAC); tumor recurrence.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-583/coif). S.G.K. reports research grant support (investigator-initiated studies) from Mauna Kea Technologies, Paris, France, and Taewoong Medical, USA (to his institution). The other author has no conflicts of interest to declare.
Comment on
-
Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).Ann Surg. 2024 Jul 1;280(1):126-135. doi: 10.1097/SLA.0000000000006144. Epub 2023 Oct 24. Ann Surg. 2024. PMID: 37873663
References
Publication types
LinkOut - more resources
Full Text Sources